Search
Help us discover a way to expand protection for the next generation.
Download the Young Minds Matter report and overview, watch video snapshots and access survey results and tables.
The Healthy Skin team, in collaboration with Elder Researchers and Aboriginal Community Members, is working to strengthen sun safety knowledge, practices, and skin cancer risk awareness among Aboriginal children and young people in Western Australia.
News & Events
Wal-yan researchers to present at largest respiratory meeting in the worldA large contingent of researchers from the Wal-yan Respiratory Research Centre are heading to Spain in September to participate in the European Respiratory Society (ERS) International Congress – the largest respiratory meeting in the world.
News & Events
Wal-yan Centre scholarship awardees to research interventions for improving lung healthAs part of the Wal-yan Respiratory Research Centre’s aim to support the next generation of scientists in children’s respiratory research, a competitive scholarship program was introduced this year.
News & events at Walyan Respiratory Research Centre.
The discoveries that have set our research apart primarily relate to the factors early in life that cause life-long respiratory problems.
Portable equipment is available to enable bedside and community-led research in rural and remote communities, including Indigenous communities where children are disproportionately affected by chronic respiratory conditions.
The lungs represent a key interface between the body and the environment.
Research
Clinical experience with SUBA-itraconazole at a tertiary paediatric hospitalItraconazole remains a first-line antifungal agent for certain fungal infections in children, including allergic bronchopulmonary aspergillosis (ABPA) and sporotrichosis, but poor attainment of therapeutic drug levels is frequently observed with available oral formulations. A formulation of 'SUper BioAvailability itraconazole' (SUBA-itraconazole; Lozanoc®) has been developed, with adult studies demonstrating rapid and reliable attainment of therapeutic levels, yet paediatric data are lacking.